Abstract
Rafael Dal-Ré and colleagues argue that the recruitment targets and performance of all site investigators in multi-centre clinical trials should be disclosed in trial registration sites before a trial starts, and when it ends.
MeSH terms
-
Biomedical Research / ethics
-
Clinical Trials as Topic* / ethics
-
Conflict of Interest
-
Disclosure / ethics
-
Humans
-
Multicenter Studies as Topic* / ethics
-
Patient Selection* / ethics
-
Research Personnel / ethics*